213 research outputs found

    Theoretical analysis of a novel integrated energy system formed by a microturbine and a exhaust fired single-double effect absorption chiller

    Get PDF
    Integrated Energy Systems (IES) combine a distributed power generation system (DG) such as a microturbine generator (MTG) or a fuel cell with thermally activated technologies (TAT) such as absorption cooling. This integration maximizes the efficiency of energy use by utilizing on-site most of the waste heat generated by DG, and reduces harmful emissions to the environment. This study investigates the energy and exergy performance of an IES. This system is comprised of an MTG with internal recuperator and a novel absorption cooling cycle. The absorption cycle is a single-double effect exhaust fired cycle, which recuperates the heat exchanged from the MTG exhaust gases using two generators at two different levels of temperature. The selection of the DG element, the TAT element and their internal configurations is based upon a real IES commercial unit that has been tested in the APEP-UCI DG testing facilities in Irvine, California. This unit has an electrical power capacity of 28 kW and a cooling capacity of 14 refrigeration tons (49.2 kW). Inputs for the thermodynamic models developed for the MTG and for the absorption cycle are derived from experimental variables that will be controlled in the testing phase. The MTG model is using empirical correlations for key model parameters (pressure ratio, turbine inlet temperature, etc.) from previous studies in order to predict the observed change in performance with part load operation. The calculated mass flow rate and temperature of the exhaust gases are inputs for the absorption cycle model, together with cooling and chilled water inlet temperatures and flow rates. Heat and mass transferefficiencies along with heat transfer coefficients for the suite of heat exchangers comprising the single-double effect absorption cycle are determined from proprietary testing data provided by the manufacturers

    A Thermodynamic Analysis of Tubular SOFC Based Hybrid Systems

    Full text link
    The goals of a research program recently completed at the University of California, Irvine were to develop analysis strategy for Solid Oxide Fuel Cell (SOFC) based systems, to apply the analysis strategy to tubular SOFC hybrid systems and to identify promising hybrid configurations. A pressurized tubular SOFC combined with an intercooled-reheat gas turbine (SureCell ™ cycle) is chosen as the Base Cycle over which improvements are sought. The humid air turbine (HAT) cycle features are incorporated to the Base Cycle resulting in the SOFC-HAT hybrid cycle which shows an efficiency of 69.05% while the Base Cycle has an efficiency of 66.23%. Exergy analysis identified the superior efficiency performance of the SOFC component. Therefore, an additional cycle variation added a second SOFC component followed by a low pressure combustor in place of the reheat combustor of the gas turbine of the SOFC-HAT hybrid. The resulting Dual SOFC-HAT hybrid has a thermal efficiency of 75.98%. The Single SOFC-HAT hybrid gives the lowest cost of electricity (3.54¢/kW-hr) while the Dual SOFC-HAT hybrid has the highest cost of electricity (4.02¢/kW-hr) among the three cycles with natural gas priced at 3/GJ.TheDualSOFC−HAThybridplantcostiscalculatedtobesignificantlyhigherbecausethefractionofpowerproducedbytheSOFC(s)issignificantlyhigherthanthatintheothercasesonthebasisof3/GJ. The Dual SOFC-HAT hybrid plant cost is calculated to be significantly higher because the fraction of power produced by the SOFC(s) is significantly higher than that in the other cases on the basis of 1100/kw initial cost for the SOFC. The Dual SOFC-HAT hybrid can only be justified in favor of the Single SOFC-HAT hybrid when price of natural gas is greater than 14/GJorffaseverecarbontaxontheorderof14/GJ or ffa severe carbon tax on the order of 180/ton of CO2 is imposed while natural gas price remains at $3/GJ. Copyright © 2001 by ASME

    Emergence and dissemination of antimicrobial resistance in Escherichia coli causing bloodstream infections in Norway in 2002-17: a nationwide, longitudinal, microbial population genomic study

    Get PDF
    Background The clonal diversity underpinning trends in multidrug resistant Escherichia coli causing bloodstream infections remains uncertain. We aimed to determine the contribution of individual clones to resistance over time, using large-scale genomics-based molecular epidemiology. Methods This was a longitudinal, E coli population, genomic, cohort study that sampled isolates from 22 512 E coli bloodstream infections included in the Norwegian surveillance programme on resistant microbes (NORM) from 2002 to 2017. 15 of 22 laboratories were able to share their isolates, and the first 22·5% of isolates from each year were requested. We used whole genome sequencing to infer the population structure (PopPUNK), and we investigated the clade composition of the dominant multidrug resistant clonal complex (CC)131 using genetic markers previously reported for sequence type (ST)131, effective population size (BEAST), and presence of determinants of antimicrobial resistance (ARIBA, PointFinder, and ResFinder databases) over time. We compared these features between the 2002–10 and 2011–17 time periods. We also compared our results with those of a longitudinal study from the UK done between 2001 and 2011. Findings Of the 3500 isolates requested from the participating laboratories, 3397 (97·1%) were received, of which 3254 (95·8%) were successfully sequenced and included in the analysis. A significant increase in the number of multidrug resistant CC131 isolates from 71 (5·6%) of 1277 in 2002–10 to 207 (10·5%) of 1977 in 2011–17 (p<0·0001), was the largest clonal expansion. CC131 was the most common clone in extended-spectrum β-lactamase (ESBL)-positive isolates (75 [58·6%] of 128) and fluoroquinolone non-susceptible isolates (148 [39·2%] of 378). Within CC131, clade A increased in prevalence from 2002, whereas the global multidrug resistant clade C2 was not observed until 2007. Multiple de-novo acquisitions of both blaCTX-M ESBL-encoding genes in clades A and C1 and gain of phenotypic fluoroquinolone non-susceptibility across the clade A phylogeny were observed. We estimated that exponential increases in the effective population sizes of clades A, C1, and C2 occurred in the mid-2000s, and in clade B a decade earlier. The rate of increase in the estimated effective population size of clade A (Ne=3147) was nearly ten-times that of C2 (Ne=345), with clade A over-represented in Norwegian CC131 isolates (75 [27·0%] of 278) compared with the UK study (8 [5·4%] of 147 isolates). Interpretation The early and sustained establishment of predominantly antimicrobial susceptible CC131 clade A isolates, relative to multidrug resistant clade C2 isolates, suggests that resistance is not necessary for clonal success. However, even in the low antibiotic use setting of Norway, resistance to important antimicrobial classes has rapidly been selected for in CC131 clade A isolates. This study shows the importance of genomic surveillance in uncovering the complex ecology underlying multidrug resistance dissemination and competition, which have implications for the design of strategies and interventions to control the spread of high-risk multidrug resistant clones. Funding Trond Mohn Foundation, European Research Council, Marie Skłodowska-Curie Actions, and the Wellcome Trust
    • …
    corecore